Afternoon Markets: Pharmaceuticals lead slow Dow revival

clock

The Dow Jones has begun to recover from a sluggish start this morning, with the market predicting imp...

The Dow Jones has begun to recover from a sluggish start this morning, with the market predicting improved June's US consumer sentiment figures. After a negative start, the Dow has recovered to sit just 4.24 points lower (0.05%) to 8,766.68. Banks and pharmaceuticals dominated the top performing stocks, with Bank of America leading the pack, up 4.1% to $13.50. It was followed by pharma companies Pfizer, Merck & Co and Proctor & Gamble, up 1.37% to $14.85, 0.84% to $26.41 and 0.77% to $52.40 respectively. The sector's performances followed a strong showing from UK pharmaceutical giant ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Equities

Deep Dive: US equities may not have peaked but do require greater selectivity

Deep Dive: US equities may not have peaked but do require greater selectivity

Amid equity rebalancing

Linus Uhlig
clock 13 June 2025 • 4 min read
Partner Insight: Robeco Emerging Markets Equities strategy - Targeting alpha in a new world of growth

Partner Insight: Robeco Emerging Markets Equities strategy - Targeting alpha in a new world of growth

Jan de Bruijn, Director, Emerging Market Equities, Robeco
clock 06 June 2025 • 5 min read
Nedgroup Investments' Rob Burdett: It is time to move underweight equities

Nedgroup Investments' Rob Burdett: It is time to move underweight equities

Reducing exposure

Rob Burdett
clock 03 June 2025 • 2 min read
Trustpilot